Arrow shareholders are reminded to vote the WHITE proxy card today to support the merger agreement with Teleflex and the election of the full slate of Arrow director nominees who will manage any events which may arise following the Annual Meeting and prior to the consummation of the merger. Arrow shareholders are cautioned NOT to return a blue proxy to the McNeil Trust.
All votes are important. For shares held by a brokerage firm or bank, Arrow shareholders should provide them with instructions on how to vote or they will be unable to vote on certain issues, including the adoption of the merger agreement. Please return the WHITE proxy card to the broker or bank to ensure that shares are voted or vote by telephone or Internet.
Shareholders with questions regarding the solicitation may contact Arrow International's proxy solicitor, Morrow & Co., Inc. toll-free at 1-800-662-5200.
Arrow develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The company's products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists and other healthcare providers. Arrow's news releases and other company information can be found on the World Wide Web at http://www.arrowintl.com. Arrow's common stock trades on the NASDAQ Global Select Market(TM) under the symbol ARRO.
In connection with the proposed acquisition of Arrow by Teleflex
Incorporated and Arrow's 2007 Annual Meeting of Shareholders, Arrow filed a
definitive proxy statement with the SEC, on August 24, 2007 and will be
filing other documents with the SEC.
|SOURCE Arrow International, Inc.|
Copyright©2007 PR Newswire.
All rights reserved